Our previous findings demonstrated that low to moderate XB130 expression were seen in normal, hyperplastic and peritumoral prostate tissues, while elevated XB130 expression was displayed in prostate cancer tissues (Data not shown), but whether XB130 can affect cellular growth and invasion in prostate cancer is unclear. Here, AFAP1L2 is linked to prostate carcinoma.